Register

SmallMolecules.com > Supplier: caymanchemical

Cayman Chemical

Our mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Company Website

Product Listing

PD 90780 (hydrate) 10 mg | ≥98%

Cayman Chemical

An inhibitor of NGF-p75 NGFR interactions

More Information Supplier Page

PD 90780 (hydrate) 5 mg | ≥98%

Cayman Chemical

An inhibitor of NGF-p75 NGFR interactions

More Information Supplier Page

PD 90780 (hydrate) 1 mg | ≥98%

Cayman Chemical

An inhibitor of NGF-p75 NGFR interactions

More Information Supplier Page

PD 98059 50 mg | ≥98%

Cayman Chemical

A MAPK pathway inhibitor and AMPK activator

More Information Supplier Page

PD 98059 10 mg | ≥98%

Cayman Chemical

A MAPK pathway inhibitor and AMPK activator

More Information Supplier Page

PD 98059 5 mg | ≥98%

Cayman Chemical

A MAPK pathway inhibitor and AMPK activator

More Information Supplier Page

PD 98059 1 mg | ≥98%

Cayman Chemical

A MAPK pathway inhibitor and AMPK activator

More Information Supplier Page

PD-1-IN-17 10 mg | ≥95%

Cayman Chemical

An inhibitor of PD-1 signaling

More Information Supplier Page

PD-1-IN-17 5 mg | ≥95%

Cayman Chemical

An inhibitor of PD-1 signaling

More Information Supplier Page

PD-1-IN-17 1 mg | ≥95%

Cayman Chemical

An inhibitor of PD-1 signaling

More Information Supplier Page

PD-1/PD-L1 Inhibitor 1 25 mg | ≥98%

Cayman Chemical

A PD-1/PD-L1 interaction inhibitor

More Information Supplier Page

PD-1/PD-L1 Inhibitor 1 10 mg | ≥98%

Cayman Chemical

A PD-1/PD-L1 interaction inhibitor

More Information Supplier Page

PD-1/PD-L1 Inhibitor 1 5 mg | ≥98%

Cayman Chemical

A PD-1/PD-L1 interaction inhibitor

More Information Supplier Page

PD-1/PD-L1 Inhibitor 1 1 mg | ≥98%

Cayman Chemical

A PD-1/PD-L1 interaction inhibitor

More Information Supplier Page

PD-1/PD-L1 Inhibitor 2 25 mg | ≥98%

Cayman Chemical

A PD-1/PD-L1 interaction inhibitor

More Information Supplier Page

PD-1/PD-L1 Inhibitor 2 10 mg | ≥98%

Cayman Chemical

A PD-1/PD-L1 interaction inhibitor

More Information Supplier Page

PD-1/PD-L1 Inhibitor 2 5 mg | ≥98%

Cayman Chemical

A PD-1/PD-L1 interaction inhibitor

More Information Supplier Page

PD-1/PD-L1 Inhibitor 2 1 mg | ≥98%

Cayman Chemical

A PD-1/PD-L1 interaction inhibitor

More Information Supplier Page

PD-1/PD-L1 Inhibitor 3 (trifluoroacetate salt) 5 mg | ≥95%

Cayman Chemical

A PD-1/PD-L1 interaction inhibitor

More Information Supplier Page

PD-1/PD-L1 Inhibitor 3 (trifluoroacetate salt) 1 mg | ≥95%

Cayman Chemical

A PD-1/PD-L1 interaction inhibitor

More Information Supplier Page

PD-1/PD-L1 Inhibitor 3 (trifluoroacetate salt) 500 µg | ≥95%

Cayman Chemical

A PD-1/PD-L1 interaction inhibitor

More Information Supplier Page

PD-1/PD-L1 Inhibitor N11 1 mg | ≥95%

Cayman Chemical

A PD-1/PD-L1 interaction inhibitor

More Information Supplier Page

PD-1/PD-L1 Inhibitor N11 5 mg | ≥95%

Cayman Chemical

A PD-1/PD-L1 interaction inhibitor

More Information Supplier Page

PDD00017273 5 mg | ≥98%

Cayman Chemical

A PARG inhibitor

More Information Supplier Page

PDD00017273 1 mg | ≥98%

Cayman Chemical

A PARG inhibitor

More Information Supplier Page

PDE4B Inhibitor 1 mg | ≥98%

Cayman Chemical

A PDE4B inhibitor

More Information Supplier Page

PDE4B Inhibitor 25 mg | ≥98%

Cayman Chemical

A PDE4B inhibitor

More Information Supplier Page

PDE4B Inhibitor 10 mg | ≥98%

Cayman Chemical

A PDE4B inhibitor

More Information Supplier Page

PDE4B Inhibitor 5 mg | ≥98%

Cayman Chemical

A PDE4B inhibitor

More Information Supplier Page

PDGFR TKI III 1 mg | ≥98%

Cayman Chemical

A PDGFRa and PDGFRß inhibitor

More Information Supplier Page

PDGFR TKI III 10 mg | ≥98%

Cayman Chemical

A PDGFRa and PDGFRß inhibitor

More Information Supplier Page

PDGFR TKI III 25 mg | ≥98%

Cayman Chemical

A PDGFRa and PDGFRß inhibitor

More Information Supplier Page

PDGFR TKI III 5 mg | ≥98%

Cayman Chemical

A PDGFRa and PDGFRß inhibitor

More Information Supplier Page

PDIC-NC 1 mg | ≥95%

Cayman Chemical

A STING activator and anticancer agent

More Information Supplier Page

PDIC-NC 10 mg | ≥95%

Cayman Chemical

A STING activator and anticancer agent

More Information Supplier Page

PDIC-NC 5 mg | ≥95%

Cayman Chemical

A STING activator and anticancer agent

More Information Supplier Page

PDIC-NN 1 mg | ≥95%

Cayman Chemical

An intermediate in the synthesis of PDIC-NS

More Information Supplier Page

PDIC-NN 10 mg | ≥95%

Cayman Chemical

An intermediate in the synthesis of PDIC-NS

More Information Supplier Page

PDIC-NN 5 mg | ≥95%

Cayman Chemical

An intermediate in the synthesis of PDIC-NS

More Information Supplier Page

PDIC-NS 1 mg | ≥95%

Cayman Chemical

A STING activator

More Information Supplier Page

PDIC-NS 10 mg | ≥95%

Cayman Chemical

A STING activator

More Information Supplier Page

PDIC-NS 5 mg | ≥95%

Cayman Chemical

A STING activator

More Information Supplier Page

PDM 11 100 mg | ≥98%

Cayman Chemical

A derivative of resveratrol

More Information Supplier Page

PDM 11 50 mg | ≥98%

Cayman Chemical

A derivative of resveratrol

More Information Supplier Page

PDM 11 25 mg | ≥98%

Cayman Chemical

A derivative of resveratrol

More Information Supplier Page

PDM 11 10 mg | ≥98%

Cayman Chemical

A derivative of resveratrol

More Information Supplier Page

PDM 2 100 mg | ≥98%

Cayman Chemical

A resveratrol-based aryl hydrocarbon receptor antagonist

More Information Supplier Page

PDM 2 50 mg | ≥98%

Cayman Chemical

A resveratrol-based aryl hydrocarbon receptor antagonist

More Information Supplier Page

PDM 2 10 mg | ≥98%

Cayman Chemical

A resveratrol-based aryl hydrocarbon receptor antagonist

More Information Supplier Page

PDMP (hydrochloride) 100 mg | ≥98%

Cayman Chemical

An inhibitor of sphingolipid biosynthesis

More Information Supplier Page